首页> 外文期刊>International Journal of Pharmacology and Toxicology >Effect of abhrak bhasma and silicon dioxide on hepatic and renal glutathione status in rats: hepatoprotection testing against single dose carbon tetrachloride induced hepatotoxicity
【24h】

Effect of abhrak bhasma and silicon dioxide on hepatic and renal glutathione status in rats: hepatoprotection testing against single dose carbon tetrachloride induced hepatotoxicity

机译:Abhrak Bhasma和二氧化硅对大鼠肝脏和肾脏谷胱甘肽状态的影响:针对单剂量四氯化碳诱导的肝毒性的肝保护试验

获取原文
获取外文期刊封面目录资料

摘要

Background: Glutathione (GSH) is an important intracellular antioxidant. Intrahepatic GSH levels are depleted in liver diseases. Objectives: In present study, effect of abhrak bhasma (an Ayurvedic drug) and silicon dioxide (SiO 2 ) on hepatic and renal GSH status against CCl 4 intoxicated male albino rats were investigated. Methods: Single dose of CCl 4 (3.0ml/kg body wt, sc) was used to induce hepatotoxicity. Graded doses (10, 20, 30 and 40mg/ kg body wt) of abhrak bhasma and SiO 2 were concurrently given with CCl 4 . Hepatic and renal GSH content was studied after 24 hrs. Results: Results showed that rats exposed to CCl 4 exhibited decreased GSH in liver. It was counteracted and maintained to normal levels by the treatment of abhrak bhasma (minimum protective dose-10mg). SiO 2 treatments did not affect GSH activity in liver significantly. Single dose of CCl 4 had not influenced GSH content in kidney alone or with any of the doses of abhrak bhasma or SiO 2 . Conclusion: CCl 4 single dose depletes GSH content significantly in liver but not in kidney. These results suggest that single dose treatment of abhrak bhasma (10mg onwards) protects GSH content and thus manages CCl 4 induced free radical generation scavenging them. Keywords : Abhrak Bhasma, Antioxidant, Glutathione, Hepatotoxicity, Silicon Dioxide.
机译:背景:谷胱甘肽(GSH)是一种重要的细胞内抗氧化剂。在肝脏疾病中,肝内GSH含量降低。目的:在本研究中,研究了阿育吠陀药(阿育吠陀药物)和二氧化硅(SiO 2)对CCl 4中毒雄性白化病大鼠肝脏和肾脏GSH状态的影响。方法:使用单剂CCl 4(3.0ml / kg体重,皮下注射)诱导肝毒性。 CCl 4同时给予abhrak bhasma和SiO 2分级剂量(10、20、30和40mg / kg体重)。 24小时后研究肝和肾中GSH的含量。结果:结果表明,暴露于CCl 4的大鼠肝脏GSH降低。通过治疗abhrak bhasma(最小保护剂量10mg)可以抵消并维持在正常水平。 SiO 2处理不会明显影响肝脏的GSH活性。单剂量的CCl 4不会单独或与任何剂量的abhrak bhasma或SiO 2一起影响肾脏中的GSH含量。结论:CCl 4单剂量可显着消耗肝脏中的GSH含量,但不会消耗肾脏的GSH含量。这些结果表明,单剂量治疗abhrak bhasma(10mg起)可保护GSH含量,从而控制CCl 4诱导的自由基生成,从而清除它们。关键字:Abhrak Bhasma,抗氧化剂,谷胱甘肽,肝毒性,二氧化硅。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号